Q4 2024 Earnings Call Transcript February 13, 2025 Blueprint Medicines Corporation misses on earnings expectations. Reported ...

Palantir is the highest performing stock in the S&P 500 (SNPINDEX: \^GSPC) -- gaining 48% as of this writing (Feb. 12). Start ...

Cracker Barrel's rural-first strategy, menu innovation, and modernization efforts position it for growth. Read here for more ...

Thursday marks 25 days since President Donald Trump was inaugurated. In that time, the S&P 500 and Nasdaq Composite have tallied their weakest start to a presidential term since 2009, according to Dow ...

On the positive side, the company has recently reported a 27% increase in Medicare Advantage members, surpassing 100,000 ...

PayPal's Q4 and FY 2024 results led to a stock decline, despite a previous 60% rally in 2024. Read why I still think PYPL ...

Is IDEXX Laboratories a good investment? Analyzing its consistent growth, innovative products, and international expansion ...

Fed’s dovish stance supports stocks like Tempus AI, OKLO, IonQ, and Snowflake. Find out why these picks in Software, Fintech, ...

Palantir’s surge in stock price shows strong AI growth, but insiders are profiting. Read why PLTR stock may struggle as ...

Investors have traditionally invested in stocks and bonds, but we think that the benefits of bonds are questionable. Check ...

Palantir's key contracts like the Army Vantage extension and TITAN system will benefit the tech giant for some time. Read ...

Pairing PLTR with PTIR can double returns, providing higher margin of safety despite inherent risks of leveraged ETFs. Click here to read why PTIR is a Hold.